Loading clinical trials...
Loading clinical trials...
Chronic-active antibody-mediated rejection (cAMR) due to de novo or pre-formed donor specific antibody (DSA) is currently considered the main cause of long-term allograft losses.Based on the aim of re...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Shahid Beheshti University of Medical Sciences
NCT06685757 · Antibody-mediated Rejection
NCT05004493 · Antibody-mediated Rejection, NMO Spectrum Disorder, and more
NCT04561986 · Antibody-mediated Rejection
NCT07444489 · Antibody-mediated Rejection
NCT07316829 · Graft Rejection, Kidney Transplantation, and more
SBMU
Tehran
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions